Both in Pharmaceuticals
Obsidian Therapeutics vs Kura Oncology
Over the past year OBX returned −16.9% and KURA returned −9.9%; their daily moves had a correlation of 0.58.
OBX −16.9% KURA −9.9%Growth of $1, one year, split-adjusted
| Metric | OBX | KURA |
|---|---|---|
| Price | $14.79 | $10.26 |
| Market cap | $913.6M | $912.7M |
| Today | +1.86% | −2.84% |
| 1 month | +11.0% | −3.7% |
| 6 months | — | +17.0% |
| Year to date | — | −1.3% |
| 1 year | — | 0.0% |
| Revenue growth (YoY) | — | +36.5% |
| Gross margin | — | 98.8% |
| Net margin | — | −327.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 11.8× |
| Net cash | — | $509.2M |
| Dividend yield | — | — |
| Volatility (60d) | — | 55.5% |
| Short % of float | 2.2% | 18.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).